Back to Results
First PageMeta Content



Establishment of cancer-specific monoclonal antibodies (CasMabs) for killing cancer cells without side effects against normal cells. Professor KATO, Yukinari The research group led by Professor Yukinari Kato, Department
Add to Reading List

Document Date: 2018-05-08 00:44:59


Open Document

File Size: 190,79 KB

Share Result on Facebook